Ferozsons Laboratories Limited (PSX:FEROZ)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
436.72
-2.89 (-0.66%)
At close: Feb 13, 2026
Market Cap18.98B +30.8%
Revenue (ttm)20.27B +27.0%
Net Income814.84M +27.2%
EPS18.74 +27.2%
Shares Out43.47M
PE Ratio23.30
Forward PEn/a
Dividend4.00 (0.92%)
Ex-Dividend DateOct 16, 2025
Volume38,762
Average Volume47,779
Open440.00
Previous Close439.61
Day's Range413.80 - 446.00
52-Week Range242.33 - 475.00
Beta0.41
RSI54.63
Earnings DateFeb 17, 2026

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1954
Employees 1,556
Stock Exchange Pakistan Stock Exchange
Ticker Symbol FEROZ
Full Company Profile

Financial Performance

In fiscal year 2025, Ferozsons Laboratories's revenue was 18.86 billion, an increase of 18.94% compared to the previous year's 15.85 billion. Earnings were 776.54 million, an increase of 13.67%.

Financial Statements